Literature DB >> 9218082

Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life.

B A Hahn1, L J Kirchdoerfer, S Fullerton, E Mayer.   

Abstract

AIM: In this study of patients with irritable bowel syndrome (IBS), we evaluated the relationship between patient-rated severity of IBS and patients' physical and psychological symptoms, health care resource use and quality of life.
METHODS: One hundred and twenty-six patients diagnosed with IBS were administered a series of questionnaires, including the Bowel Symptom Checklist, the Symptom Checklist-90-R (a psychological symptom checklist), the IBSQOL (a disease-specific quality of life instrument), the SF-36 (a general health status instrument), and a health resource utilization assessment that measured health care use, time loss from work, impact on productivity, and days worked with symptoms.
RESULTS: No relationship was found between IBS severity and gastrointestinal symptoms, except for a feeling of unpassed stool. IBS severity was also not related to psychological symptom severity. Direct traditional indicators of resource use (e.g. physician visits, hospital admissions and emergency room visits) were not significantly associated by severity level; however, indirect measures of resource use (e.g. number of days with pain, productivity and number of bed days) were related to severity. Quality of life was clearly associated with perceived IBS severity. Patients who rated themselves as very severe reported the lowest scores and had the poorest health for all quality of life dimensions measured.
CONCLUSIONS: These findings suggest that perceived IBS severity is defined by the limitations the disease imposes, rather that by the symptoms. Patients with reduced productivity and decreased functioning for most of the quality of life indicators were those who rated their IBS as very severe.

Entities:  

Mesh:

Year:  1997        PMID: 9218082     DOI: 10.1046/j.1365-2036.1997.00160.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  37 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful?

Authors:  Natasha A Koloski; Philip M Boyce; Michael P Jones; Nicholas J Talley
Journal:  Qual Life Res       Date:  2011-08-11       Impact factor: 4.147

3.  Optimizing outcomes with alosetron hydrochloride in severe diarrhea-predominant irritable bowel syndrome.

Authors:  Susan L Lucak
Journal:  Therap Adv Gastroenterol       Date:  2010-05       Impact factor: 4.409

Review 4.  How do SSRIs help patients with irritable bowel syndrome?

Authors:  F Creed
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

5.  Symptom Comparisons Between Asian American and White American Women With Irritable Bowel Syndrome.

Authors:  Claire Jungyoun Han; Chaoqun Dong; Monica E Jarrett; Margaret M Heitkemper
Journal:  Gastroenterol Nurs       Date:  2018 May/Jun       Impact factor: 0.978

6.  Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.

Authors:  Xavier Badia; Fermin Mearin; Agustin Balboa; Eva Baró; Ellen Caldwell; Mercedes Cucala; Manuel Díaz-Rubio; Arturo Fueyo; Julio Ponce; Mentse Roset; Nicholas J Talley
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

7.  Irritable bowel syndrome symptom patterns: frequency, duration, and severity.

Authors:  B Hahn; M Watson; S Yan; D Gunput; J Heuijerjans
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

Review 8.  The burden of IBS: looking at metrics.

Authors:  Brennan M R Spiegel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

9.  Quality of life in women with lipoedema: a contextual behavioral approach.

Authors:  Joanna E Dudek; Wojciech Białaszek; Paweł Ostaszewski
Journal:  Qual Life Res       Date:  2015-07-28       Impact factor: 4.147

10.  Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory.

Authors:  Pingguang Lei; Guanghe Lei; Jianjun Tian; Zengfen Zhou; Miao Zhao; Chonghua Wan
Journal:  Int J Colorectal Dis       Date:  2014-08-01       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.